NVRO Stock Summary and Trading Ideas (Nevro Corp. | NYSE:NVRO)

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Nevro Corp. trades on the NYSE stock market under the symbol NVRO.

As of May 13, 2024, NVRO stock price climbed to $10.19 with 534,013 million shares trading.

NVRO has a beta of 1.84, meaning it tends to be more sensitive to market movements. NVRO has a correlation of 0.18 to the broad based SPY ETF.

NVRO has a market cap of $374.26 million. This is considered a Small Cap stock.

Last quarter Nevro Corp. reported $102 million in Revenue and -$.70 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.35.

In the last 3 years, NVRO stock traded as high as $182.45 and as low as $9.76.

The top ETF exchange traded funds that NVRO belongs to (by Net Assets): VTI, IWM, VXF, VB, VBK.

NVRO has underperformed the market in the last year with a price return of -63.5% while the SPY ETF gained +27.8%. NVRO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.6% and -10.0%, respectively, while the SPY returned +4.3% and +2.5%, respectively.

NVRO support price is $9.39 and resistance is $10.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVRO stock will trade within this expected range on the day.